Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Slows the digestion of starch to blunt post-meal sugar rises. | First-choice tablet for type 2 diabetes. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Alpha-glucosidase inhibitors | Biguanides |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Type 2 diabetes (add-on) | Type 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label) |
| How it works | Slows how quickly starch becomes sugar in the gut. | Makes your liver release less sugar and helps your body respond to insulin. |
| Starts working | With the first mouthful | Blood sugar improves over 1–2 weeks |
| Half-life | 2 hours (not significantly absorbed) | About 6 hours |
| Typical adult dose | 25–50 mg at the start of each main meal, increasing to 100 mg three times a day. | Start 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g). |
| Forms | Tablet | Tablet, Modified-release tablet, Oral solution, Combination tablets |
| Common side effects | Wind, Bloating, Diarrhoea, Abdominal pain | Diarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetite |
| Serious side effects | Raised liver enzymes (high doses), Bowel obstruction (rare) | Lactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term use |
| Don't take if | Inflammatory bowel disease; Bowel obstruction or hernia; Severe kidney impairment; Cirrhosis | Severe kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver disease |
| Alcohol | Best to limit. Alcohol can alter blood sugar control. | Best to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar. |
| Pregnancy | Usually avoidedNot recommended; insulin is the standard. | Generally considered safeWidely used for gestational and type 2 diabetes in pregnancy. |
| Breastfeeding | Usually avoidedNot recommended. | Generally considered safeConsidered acceptable. |
| In use since | — | 1957 |
| Brand names | United States: PrecoseUnited Kingdom: GlucobayIndia: Glucobay, Acarbose (generic) | United States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, Obimet |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BF01 | A10BA02 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker